Chyle - Qualitative Detection, in Visit Clinic

The diagnostic tests for chyle (chylous effusion) include analysis of the fluid: a milky appearance, lymphocyte-predominant cells, and a high triglyceride concentration—typically >110 mg/dL is diagnostic (50–110 mg/dL equivocal). Detection of chylomicrons by lipoprotein electrophoresis confirms chyle. A cholesterol/triglyceride ratio <1 and Sudan III staining for fat droplets may also support the diagnosis.

Chyluria is suspected when urine appears milky or cloudy, often with a floating fat layer and postprandial worsening. Laboratory tests include urine microscopy (fat globules), Sudan III stain, positive ether test (clears milky urine), raised urinary triglycerides and detection of chylomicrons. Urine dipstick and culture exclude infection. Imaging (lymphangiography or CT lymphangiography) localizes lymphatic–urinary fistulae.

Suspect a chyle leak with milky/cloudy surgical‑drain or pleural output, especially if it increases after fatty meals or suddenly rises. Confirm by testing the fluid: triglycerides >110 mg/dL (or presence of chylomicrons) and lymphocyte predominance with low cholesterol. Imaging (lymphoscintigraphy/lymphangiography, CT/MR) localizes the leak. Large leaks may cause swelling, respiratory symptoms, and protein/electrolyte losses.

Chyle is a milky fluid formed in the small intestine during fat digestion, composed of lymph and emulsified fats called chylomicrons. Absorbed by intestinal lacteals, it travels through the lymphatic system and thoracic duct into the bloodstream. Chyle appears after fatty meals; problems like chylothorax or chylous ascites occur when it leaks into the chest or abdominal cavities due to lymphatic injury or disease.

A chyle leak can be serious. Loss of lymphatic fluid causes dehydration, protein, fat and electrolyte depletion, immune suppression and malnutrition. Small leaks may resolve with dietary changes, drainage and medication, but large or persistent leaks often require surgical repair. Prompt diagnosis and treatment are important to prevent complications and, in severe cases, life‑threatening consequences.

Diagnosis of chylous effusion is confirmed by analysis of pleural or peritoneal fluid: a milky appearance plus elevated triglycerides (>110 mg/dL diagnostic; 50–110 mg/dL indeterminate), and demonstration of chylomicrons on lipoprotein analysis (or electrophoresis) provides definitive confirmation. Fluid is often lymphocyte-predominant and has a low cholesterol-to-triglyceride ratio and may follow thoracic duct injury or malignancy.